Registro:

Referencias:

• Beverley, P., Immunology of cancer (1997) Introduction to the Cellular and Molecular Biology of Cancer, pp. 311-329. , Franks LM, Teich NM, Eds. New York: Oxford University Press
• Sheil, A.G.R., Development of malignancy following renal transplantation in Australia and New Zealand (1992) Transplantation Proc, 24, pp. 1275-1279
• Biskind, M., Biskind, G., Development of tumors in the rat ovary after transplantation into the spleen (1944) Proc Soc ExpBiol Med, 55, pp. 176-179
• Lux, V.A.R., Tesone, M., Larrea, G.A., Libertun, C., High correlation between prolactinemia, 125-I hLH binding and progesterone secretion by an experimental luteoma (1984) Life Sci, 35, pp. 2345-2352
• Lux-Lantos, V.A.R., Thyssen, S.M., Chamson-Reig, A., Libertun, C., Effect of a gonadotropin releasing hormone analog on an experimental ovarian tumor: Direct and indirect actions (1995) Life Sci, 57, pp. 291-300
• Chamson-Reig, A., Lux-Lantos, V.A.R., Tesone, M., Libertun, C., GnRH receptors and GnRH endocrine effects on luteoma cells (1997) Endocrine, 6, pp. 165-171
• Chamson-Reig, A., Bianchi, M.S., Rey-Roldán, E.B., Sorianello, E., Libertun, C., Lux-Lantos, V.A., Development of an experimental ovarian tumor over a year in the rat (1999) Life Sci, 65, pp. 1275-1285
• Hockl, P., Sorianello, E., Chamson-Reig, A., Campo, S., Groome, N., Libertun, C., Lux-Lantos, V., Inhibins and FSH in the early development of an experimental ovarian tumor (2000) International workshop on inhibins, activins, follistatins, p. 60. , Monash Medical Center, Melbourne, Australia. Abstract book
• Chamson-Reig, A., Pignataro, O.P., Libertun, C., Lux-Lantos, V., Alterations in intracellular messengers mobilized by gonadotropin-releasing hormone in an experimental ovarian tumor (1999) Endocrinology, 148, pp. 3573-3580
• Clark, R.G., Holder, A.T., Ovarian-splenic autotransplantation: Evidence that oestrogen does not inhibit hepatic somatomedin generation (1984) J Endocrinol, 103, pp. 43-47
• Vom Saal, F.S., Finch, C.E., Reproductive senescence: Phenomena and mechanisms in mammals and selected vertebrates (1986) The Physiology of Reproduction, pp. 2351-2413. , Knobil E, Neill JD, Eds. New York: Raven Press
• Waterhouse, J., (1976) Cancer Incidence in Five Continents, p. 15. , Lyons, France: IARC Scientific Publications
• Rao, R.B., Slotman, B., Endocrine factors in common epithelial ovarian cancer (1991) Endocrine Rev, 12, pp. 14-26
• Willemsen, W., Kruitwagen, R., Bastiaans, B., Hanselaar, T., Rolland, R., Ovarian stimulation and granulosa-cell tumour (1993) Lancet, 341, pp. 986-988
• Yen, S.S.C., The polycystic ovary syndrome (1980) Clin Endocrinol, 12, pp. 177-208
• MacLeod, A.F., Wleeler, M.J., Gordon, C., Lowy, C., Sonksen, P.H., Conaglen, J.V., Effect of long-term inhibition of gonadotrophin secretion by the gonadotrophin-releasing hormone agonist, buserelin, on sex steroid secretion and ovarian morphology in polycystic ovary syndrome (1989) J Endocrinol, 125, pp. 317-325
• Zinkernagel, R.M., Ehl, S., Aichele, P., Oehen, S., Kündig, T., Hengartner, H., Antigen localisation regulates immune response in a dose- and time-dependent fashion: A geographical view of immune reactivity (1997) Immunol Rev, 156, p. 209
• Sigal, N.H., Dumont, F.J., Cyclosporin, A., FK-506, and rapamycin: Pharmacologic probes of lymphocyte signal transduction (1992) Annu Rev Immunol, 10, pp. 519-560
• Arai, S., Vogelsang, G.B., Management of graft-versus-host disease (2000) Blood Rev, 14, pp. 190-204
• Fauci, A.S., Dale, D.C., Balow, J.E., Glucocorticosteroid therapy: Mechanisms of action and clinical considerations (1976) Ann Intern Med, 84, pp. 304-315
• De Bosscher, K., Shmitz, M.L., Vanden Berghe, W., Plaisance, S., Fiers, W., Haegeman, G., Glucocorticoid-mediated repression of nuclear factorκB-dependent transcription involves direct interference with transactivation (1997) Proc Natl Acad Sci U S A, 94, pp. 13504-13509
• Rondinone, C.M., Schillaci, R., Castillo, M.B., Roldán, A., Inhibitory Effect of 11-hydroxypregna-1,4-diene-3,20-dione (A HOP) on lymphocyte proliferation (1991) Clin Expt Immun, 86, pp. 311-314
• Ashwell, J.D., Lu, F.W.M., Vacchio, M.S., Glucocorticoids in T cell development and function (2000) Annu Rev Immunol, 18, pp. 309-345
• Rondinone, C.M., Schillaci, R., Lantos, C.P., Roldán, A., Appearance and persistence of 11-hydroxypregna-1,4-diene-3,20-dione (ΔHOP) effect 'in vivo' (1989) Acta Physiol Pharmacol Latinoamer, 39, p. 181
• Murphy, P., Alexander, P., Senior, P.V., Fleming, J., Kirkham, N., Taylor, I., Mechanisms of organ selective tumour growth by bloodborne cancer cells (1988) Br J Cancer, 57, pp. 19-31
• Hojo, M., Morimoto, T., Maluccio, M., Asano, T., Morimoto, K., Lagman, M., Shimbo, T., Suthanthiran, M., Cyclosporine induces cancer progression by a cell-autonomous mechanism (1999) Nature, 397, pp. 530-534
• DeSombre, E.R., Arbogast, L.Y., Effect of the antiestrogen CI 628 on the growth of rat mammary tumors (1974) Cancer Res, 34, pp. 1971-1974
• Sokal, R.R., Rohlf, F.J., (1995) Biometry, , New York: W.H. Freeman and Co
• Lison, L., (1976) Datos enumerativos. Comparación de proporciones. Estadística aplicada a la biología experimental, pp. 307-327. , Buenos Aires: Editorial Universitaria de Buenos Aires
• Sorianello, E., Fritz, S., Beyer, C., Hales, D., Mayerhofer, A., Libertun, C., Lux-Lantos, V., Development of an experimental ovarian tumor: Immunocytochemical analysis Eur J Endocrinol, , In Press
• Coirini, H., Flores, D., Vega, M.C., Gonzalez Deniselle, M.C., De Nicola, A.F., Binding of the anti-inflammatory steroid deflazacort to glucocorticoid receptors in brain and peripheral tissues: In vivo and in vitro studies (1994) J Steroid Biochem Mol Biol, 49, pp. 43-49
• Whiting, P.H., Simpson, J.G., Davidson, R.J.L., Thomson, A.W., Pathological changes in rats receiving cyclosporin A at immunotherapeutic dosage for 7 weeks (1983) Br J Exp Pathol, 64, pp. 437-444
• Damoiseaux, J.G.M.C., Beijleveld, L.J.J., Van Breda Vriesman, P.J.C., (1997) Clin Immunol Immunopathol, 82, pp. 197-202
• Hedger, M.P., Drummond, A.E., Robertson, D.M., Risbridger, G.P., De Kretset, D.M., Inhibin and activin regulate [3H]thymidine uptake by rat thymocytes and 3T3 cells in vitro (1989) Mol Cell Endocrinol, 61, pp. 133-138
• Sabharwal, P., Varma, S., Growth hormone synthesized and secreted by human thymocytes acts via insulin-like growth factor I as an autocrine and paracrine growth factor (1996) J Clin Endocrinol Metab, 81, pp. 2663-2669
• Beschorner, W.E., Divic, J., Pulido, H., Yao, X., Kenworthy, P., Bruce, G., Enhancement of thymic recovery after cyclosporine by recombinant human growth hormone and insulin-like growth factor I (1991) Transplantation, 52, pp. 879-884
• Esquifino, A.I., Moreno, M.L., Agrasal, C., Villanúa, M.A., Effects of cyclosporine on ovarian function in sham-operated and pituitary-grafted young female rats (1995) Proc Soc Exp Biol Med, 208, pp. 397-403
• Pellegrini, I., Lebrun, J.-J., Ali, S., Kelly, P.A., Expression of prolactin and its receptor in human lymphoid cells (1992) Mol Endocrinol, 6, pp. 1023-1031
• Russell, D.H., Matrisian, L., Kibler, R., Larson, D.F., Poulos, B., Magun, B.E., Prolactin receptors on human lymphocytes and their modulation by cyclosporine (1984) Biochem Biophys Res Commun, 121, pp. 899-906
• Woody, M.A., Welniak, L.A., Sun, R., Tian, Z.G., Henry, M., Richards, S., Raziuddin, A., Murphy, W.J., Prolactin exerts hematopoietic growth-promoting effects in vivo and partially counteracts myelosuppression by azidothymidine (1999) Exp Hematol, 27, pp. 811-816
• Van Nierkerk, C.C., Ramaekers, F.C., Hanselaar, A.G., Alderweireldt, J., Poels, L.G., Changes in expression of differentiation markers between normal ovarian cells and derived tumors (1993) Am J Pathol, 142, pp. 157-177
• Ochsenbein, A.F., Sierro, S., Odermatt, B., Pericin, M., Karrer, U., Hermans, J., Hemmi, S., Zinkernagel, R.M., Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction (2001) Nature, 411, pp. 1058-1064

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------